Small and colorful stones make beautiful mosaics: fragment-based chemogenomics
- 30 April 2013
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 18 (7-8), 323-330
- https://doi.org/10.1016/j.drudis.2012.12.003
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Design, Synthesis, and Structure–Activity Relationships of Highly Potent 5-HT3 Receptor LigandsJournal of Medicinal Chemistry, 2012
- Crystal Structure-Based Virtual Screening for Fragment-like Ligands of the Human Histamine H1 ReceptorJournal of Medicinal Chemistry, 2011
- Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3ABioorganic & Medicinal Chemistry Letters, 2011
- Status of GPCR Modeling and Docking as Reflected by Community-wide GPCR Dock 2010 AssessmentStructure, 2011
- Structure of the human histamine H1 receptor complex with doxepinNature, 2011
- Docking for fragment inhibitors of AmpC β-lactamaseProceedings of the National Academy of Sciences of the United States of America, 2009
- Chemical substructures that enrich for biological activityBioinformatics, 2008
- A Hydrogen Bond in Loop A Is Critical for the Binding and Function of the 5-HT3 ReceptorBiochemistry, 2008
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- Chemogenomic approaches to rational drug designBritish Journal of Pharmacology, 2007